← Eichor
Study identifier: NCT06732141 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remote Anxiety Management for ICS-resistant Asthma Study

Condition: Asthma  ·  Sponsor: First Affiliated Hospital of Ningbo University

PhaseNA
Planned participants216
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study, the Remote Anxiety Management for ICS-resistant Asthma Study (RAMICS), explores strategies to improve medication adherence and anxiety management in asthma patients who are resistant to using inhaled corticosteroids (ICS) due to anxiety. Asthma is a chronic respiratory disease affecting millions worldwide, and ICS therapy is essential for controlling symptoms and preventing severe exacerbations. However, many patients struggle with adherence, especially those with anxiety about ICS side effects. RAMICS is a multicenter, open-label, randomized controlled trial designed to evaluate the effectiveness of personalized telephone-based interventions, including medication education, progressive muscle relaxation (PMR), motivational interviewing (MI), and lung rehabilitation guidance. The study will enroll 216 adult asthma patients with poor ICS adherence and clinically significant anxiety. Participants will be randomized into two groups: the intervention group, receiving weekly telephone sessions, and the control group, receiving standard follow-up calls. The study aims to assess improvements in ICS adherence, reductions in anxiety and depression, better asthma symptom control, and enhanced quality of life. Outcomes will be evaluated immediately after the 8-week intervention and during a 3-month follow-up. By addressing both psychological and medication adherence challenges, this research aims to provide practical solutions for improving asthma management.

This description comes directly from the study's public registry record.

Talk to the study team

Chao Cao  ·  +86-0574-87089878  ·  caocdoctor@163.com

Shiyi He  ·  +86-0574-87089878  ·  shiyihii@163.com

Always discuss trial participation with your own doctor first.

Locations (11)

Second Affiliated Hospital of Harbin Medical UniversityHarbin, ChinaRecruiting
Anhui Chest HospitalHefei, ChinaRecruiting
The First Affiliated Hospital of Anhui Medical UniversityHefei, ChinaRecruiting
The Second Affiliated Hospital of Anhui Medical UniversityHefei, ChinaRecruiting
Jingzhou Central HospitalJingzhou, ChinaRecruiting
Haishu District People's HospitalNingbo, ChinaNot Yet Recruiting
Ningbo Medical Center Lihuili HospitalNingbo, ChinaRecruiting
Qianhu HospitalNingbo, ChinaRecruiting
The First Affiliated Hospital of Ningbo UniversityNingbo, ChinaRecruiting
Ninghai County First HospitalNinghai, ChinaRecruiting
Taizhou Central HospitalTaizhou, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06732141